Paragon Bioteck Inc. is a privately-held ophthalmic pharmaceutical and medical device company focused on the development and commercialization of products addressing unmet medical needs in the fight to protect and preserve eyesight. Its products are used by ophthalmologists and optometrists around the world to treat a variety of ocular conditions, including dry eye, glaucoma, and blepharitis, among others.
Founded in 2009 by a group of ophthalmologists and experienced industry executives.
Launched its first product, an ocular lubricant, in 2010.
Received FDA clearance for its second product, a punctal plug delivery system, in 2012.
Continued to expand its product portfolio through in-house research and strategic partnerships.
Achieved significant growth and success in the ophthalmology market, becoming a recognized leader in the space.
A global pharmaceutical company with a focus on developing, manufacturing, and commercializing branded pharmaceuticals, devices, and biologic products.
A Swiss multinational pharmaceutical company that develops and manufactures a range of healthcare products, including pharmaceuticals, eye care products, and generic drugs.
A Japanese pharmaceutical company specializing in the development and marketing of ophthalmic pharmaceuticals, medical devices, and diagnostic reagents.
A dissolvable punctum plug that provides sustained relief for dry eye symptoms by blocking tear outflow.
A gentle, non-irritating foam cleanser that effectively removes debris from eyelids and eyelashes, helping to treat blepharitis and other ocular conditions.
A mydriatic agent that is used to dilate the pupil and facilitate eye exams and procedures.
Paragon Bioteck Inc. is a privately-held ophthalmic pharmaceutical and medical device company focused on the development and commercialization of products addressing unmet medical needs in the fight to protect and preserve eyesight.
Paragon Bioteck Inc.'s main products include Comfortear Lacrisolve, Paragon BioTeck Eyelid Cleansing Foam, and Phenylephrine Hydrochloride Ophthalmic Solution.
Paragon Bioteck Inc.'s products are used to treat a variety of ocular conditions, including dry eye, glaucoma, and blepharitis, among others.
Paragon Bioteck Inc. was founded in 2009 by a group of ophthalmologists and experienced industry executives.
Competitors of Paragon Bioteck Inc. in the ophthalmology market include Allergan, Novartis International AG, and Santen Pharmaceutical Co., Ltd., among others.